Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2481-2021Class II

BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375

Leica Microsystems, Inc. / initiated 2021-07-30 / Terminated / root cause: labeling and UDI

Leica Microsystems, Inc. began a recall of BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375 on . FDA classified it as Class II and gives the reason as "Product may not perform as specified in IFU". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2481-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Leica Microsystems, Inc.
Product
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
Product code
NJT Immunohistochemistry Reagents And Kits
Reason for recall
Product may not perform as specified in IFU.
Root cause tag
labeling and UDI
FDA root cause
Unknown/Undetermined by firm
Action
The firm notified their consignees by email on 07/30/2021. The notice explained the issue and requested destruction of the product.
Quantity in commerce
237 units
Distribution
US Nationwide distribution.
Product codes and lots
Product Code PA0375, Lot 69909

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2481-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2481-2021Class IITerminatedVoluntary: Firm initiated